Neonatal Jaundice for NEET PG: Physiological vs Pathological Criteria and the Phototherapy Logic

Neonatal jaundice is common, usually harmless, and occasionally dangerous. The exam skill is knowing which of those three situations is in front of you. This guide sorts the criteria that separate physiological from pathological jaundice, the structure behind phototherapy and exchange decisions, and the conditions you must not miss.

Two guideline families matter for an Indian student. The Ministry of Health and Family Welfare (MoHFW) standard treatment guideline from 2016 is built on older AAP 2004 and NICE 2010 recommendations. The AAP 2022 revision is the current guideline, and this post reads it through an AIIMS commentary in Indian Pediatrics.

Key Takeaways

• Early jaundice that appears at 24-72 hours and then falls is usually physiological. Jaundice in the first 24 hours, yellow palms and soles, neurological signs, or a level above the 95th centile on an age-specific nomogram is "serious" jaundice.

• Conjugated hyperbilirubinemia is pathological at any age. Indian sources give two different direct bilirubin cut-offs (IAP and MoHFW), so know both and who states them.

• AAP 2022 uses hour-specific thresholds for each completed week of gestation, raised from 2004, and adds an escalation-of-care step when TSB comes within 2 mg/dL of the exchange threshold.

• Exchange transfusion is given for advanced acute bilirubin encephalopathy signs irrespective of the bilirubin level.

• Pale stools with dark urine in a well-looking baby suggest biliary atresia, and Kasai surgery works best before 60 days.

Neonatal Jaundice: Physiological vs Pathological Criteria

Physiological jaundice is the early, self-limiting rise in bilirubin that most newborns show. According to the MoHFW standard treatment guideline, jaundice becomes visible once total serum bilirubin (TSB) exceeds 5-7 mg/dL and usually appears at 24-72 hours of age. In a term baby TSB rises until about day 3 and then falls, though it may take weeks to drop below 2 mg/dL. In a preterm baby the peak comes later, around day 3-7.

The same guideline notes that about 60% of term and 80% of preterm infants are jaundiced in the first week. About 10% of breastfed infants are still jaundiced at one month. That is why "jaundice" alone is not a diagnosis; timing, pattern and associated signs decide the label.

When jaundice is "serious"

The MoHFW guideline lists four triggers, and any one makes the jaundice serious rather than physiological:

• Visible jaundice in the first 24 hours of life.
• Yellow palms and soles at any time.
• Signs of acute bilirubin encephalopathy (ABE) or kernicterus: hypertonia, arching, retrocollis, opisthotonus, convulsion, fever, high-pitched cry.
• TSB or transcutaneous bilirubin (TcB) above the 95th centile on an age-specific nomogram.

Rate of rise and prolonged jaundice

AAP 2022 gives a rate-of-rise rule for hemolysis. A rise of 0.3 mg/dL per hour or more in the first 24 hours, or 0.2 mg/dL per hour or more afterwards, is exceptional and should prompt a direct antiglobulin test (DAT), as summarised in the AIIMS commentary.

Prolonged jaundice has its own work-up. AAP 2022 defines it as jaundice beyond 3-4 weeks in breastfed babies or beyond 2 weeks in formula-fed babies, and advises TSB with direct bilirubin plus evaluation for hypothyroidism. The MoHFW guideline asks, beyond 3 weeks, for total and direct bilirubin, a thyroid profile, urine reducing substances (for galactosemia), and urine routine and culture.

Kramer's Rule for Clinical Assessment of Neonatal Jaundice

Kramer's rule links the cephalocaudal spread of yellow colour to an approximate TSB. The MoHFW guideline reproduces it, citing Kramer 1969.

These ranges come from one Indian guideline figure, so textbook values may differ slightly, and zones 4 and 5 overlap. The practical points are more important than the numbers. Examine the naked baby in bright natural light, press on the skin to blanch it, and look at the gums and sclerae.

Visual inspection is reasonably accurate when TSB is below 12-14 mg/dL, and absence of jaundice on inspection reliably excludes it. AAP 2022 goes further and judges visual estimation too inaccurate for deciding the level, so it advises objective TcB or TSB at 24-48 hours. TcB can be used from 35 weeks of gestation and after 24 hours of age, but it is unreliable above a TSB of 14 mg/dL. If TcB is above 14, send a serum bilirubin.

Phototherapy Thresholds in Neonatal Jaundice: AAP 2022 Structure

The AAP 2022 guideline does not use one number for all babies. As the AIIMS commentary explains, thresholds are hour-specific for each completed week of gestation. One track covers 35 to 40 weeks without neurotoxicity risk factors, and a second track covers infants with such factors.

The guideline publishes these thresholds as graphs, and the exact values are best read from those graphs rather than memorised from a summary. What you should carry into the exam is the logic. Thresholds were raised at every gestation compared with 2004, because bilirubin neurotoxicity was found to occur well beyond the old thresholds. East Asian race, maternal age and male sex were omitted from the 2022 list of risk factors for significant hyperbilirubinemia, and Down syndrome was added.

Neurotoxicity risk factors

AAP 2022 lists five neurotoxicity risk factors: gestational age under 38 weeks, albumin under 3 g/dL, sepsis, hemolytic conditions (isoimmune disease, G6PD deficiency and others), and significant clinical instability in the previous 24 hours. In 2004, acidosis, asphyxia and lethargy were named separately; they are now folded into clinical instability.

A study aid for these: GASH-S (Gestation under 38 weeks, Albumin under 3 g/dL, Sepsis, Hemolysis, Sick or unstable). This mnemonic is the author's own memory device, not a term used in the guideline.

What changed from 2004 to 2022

Practical rules during treatment

TSB is the definitive test. Send a TSB if TcB is within 3 mg/dL of the phototherapy threshold or is 15 mg/dL or more. During phototherapy, measure TSB within 12 hours of starting.

After stopping, rebound is more likely with gestation under 38 weeks, phototherapy started before 48 hours, or hemolytic disease. In those babies, re-measure TSB 6-12 hours after stopping. Otherwise, repeat it the next day (a minimum of 12 hours, preferably 24 hours).

Home phototherapy is allowed only when all of these hold: gestation of 38 weeks or more, age over 48 hours, feeding well, no neurotoxicity risk factors, no previous phototherapy, TSB no more than 1 mg/dL above the threshold, an LED device, and daily TSB.

The MoHFW guideline adds that sunlight is not a treatment. It also lists no role for phenobarbitone or tin mesoporphyrin.

Exchange Transfusion and Escalation of Care

Exchange transfusion is the rescue step when phototherapy cannot keep up or the brain is at risk. Per AAP 2022, it is indicated for signs of ABE or for TSB at the exchange cut-offs. Any infant with advanced ABE signs (hypertonia, retrocollis, apnea) gets exchange irrespective of the TSB. The MoHFW guideline says the same for suspected bilirubin encephalopathy.

AAP 2022 introduces escalation of care. When TSB is within 2 mg/dL of the exchange threshold, treat it as a medical emergency:

1. Admit immediately to a NICU that can perform exchange transfusion.
2. Start intensive phototherapy and IV hydration.
3. Send albumin, TSB, direct bilirubin, blood group, cross-match, CBC and G6PD.
4. Repeat TSB every 2 hours until it falls below the escalation level.

Intravenous immunoglobulin (IVIG) is optional in isoimmune hemolytic disease under AAP 2022: 0.5-1 g/kg over 2 hours, repeated after 12 hours if needed. The MoHFW guideline does not recommend routine IVIG for Rh or ABO disease, so the two documents differ here.

Exchange transfusion details from the MoHFW guideline

The exchange is double-volume: volume = 2 x (80-100 mL/kg) x birth weight in kg. For Rh isoimmunisation use O Rh-negative packed cells in AB plasma. For ABO isoimmunisation use O group (Rh-compatible) packed cells in AB plasma, or O whole blood Rh-compatible with the baby. Cross-match against the maternal plasma. AAP 2022 advises a hematocrit of 40% so that extra albumin is available.

Phototherapy failure in the exchange or pre-exchange zone means no decline of 1-2 mg/dL after 4-6 hours, or inability to keep TSB below the exchange level. The guideline also recommends developmental assessment at 3 and 18 months after exchange, and BERA before 3 months.

Hemolytic and Genetic Causes of Neonatal Jaundice

Most neonatal jaundice is physiological or due to ABO or Rh incompatibility, according to the IAP cholestasis consensus. In Rh-negative mothers, antibody screening is advised, and a positive screen should lead to testing the infant's blood group and DAT. A DAT that is positive only because of maternal anti-D prophylaxis may be ignored, per AAP 2022.

The MoHFW work-up for a baby on phototherapy includes TSB, blood group and DAT (if the mother is O or Rh-negative), G6PD, peripheral smear and reticulocyte count. In Rh isoimmunisation, TSB is checked every 6-8 hours in the first 24-48 hours. If the DAT is positive in an Rh-negative mother's baby, AAP 2022 advises TSB 4-hourly twice and then 12-hourly, with early phototherapy.

Crigler-Najjar and Gilbert syndromes

These are the inherited unconjugated disorders. The comparison below follows a 2024 case report and review.

Breastfeeding and Breast Milk Jaundice

AAP 2022 renames breastfeeding jaundice as suboptimal intake hyperbilirubinemia. When TSB is near the threshold and the history or weight loss suggests poor intake, formula supplementation can be considered. Weight loss above 3% per 24 hours of age, or above 7% cumulative, is a risk marker in the MoHFW guideline.

Management of the breastfed jaundiced baby is conservative. The MoHFW guideline advises 8-12 feeds a day and supplementation only for dehydration or weight loss over 10% from birth, preferably with expressed breast milk. Do not interrupt breastfeeding, and avoid routine IV fluids, honey or dextrose water. AAP 2022 also advises against water or dextrose supplementation.

Breast milk jaundice, the prolonged form, has no agreed mechanism. A systematic review found no consensus on which milk constituents are responsible.

Direct Hyperbilirubinemia and Biliary Atresia

Conjugated hyperbilirubinemia is pathological at any age, so it needs its own cut-off. The two Indian sources define it differently, and an exam option may follow either.

The MoHFW guideline adds that conjugated bilirubin should not be subtracted from TSB when deciding on phototherapy or exchange.

Red flags and biliary atresia

Jaundice with dark urine that stains the diaper, with or without pale stools, suggests neonatal cholestasis and calls for early referral. In biliary atresia (BA), babies look well and grow normally. The IAP consensus reports onset of jaundice at 3-12 days in BA versus 16-24 days in hepatocellular causes.

A stool colour card has shown value: in a Taiwan study, pale stools detected BA before 60 days with a sensitivity of 89.7%, specificity of 99.9% and positive predictive value of 28.6%. BA accounted for 34% of Indian neonatal cholestasis in a pooled eight-centre analysis.

Timing of surgery drives outcome. Kasai portoenterostomy before 60 days established adequate bile flow in 64.7% of infants, compared with 31.8% when done later. The consensus gives under 60 days as the recommended age for presentation and evaluation, while Indian babies reached tertiary centres at a mean age of 2.8-3.9 months against a desired 4-6 weeks.

For diagnosis, an intra-operative cholangiogram is the gold standard. Ultrasound after a 4-hour fast may show the triangular cord sign. A bilirubin above 6 mg/dL three months after Kasai is a reason to refer for transplant.

For a broader view of pre-hepatic, hepatic and post-hepatic causes, see jaundice types for NEET PG.

Kernicterus and Bilirubin Encephalopathy

Acute bilirubin encephalopathy is the early, acute phase, and kernicterus is the chronic sequela. A review of the clinicopathological spectrum lists the signs of ABE: decreased feeding, lethargy, hypotonia or hypertonia, a high-pitched cry, retrocollis, opisthotonus, the setting-sun sign, fever and seizures. Death can occur. Apnea can be an early abnormality.

Chronic bilirubin encephalopathy shows a tetrad, typically evident after 1 year:

1. Abnormal motor control, movements or tone.
2. Auditory processing disturbance, with or without hearing loss.
3. Oculomotor impairment, especially upward vertical gaze.
4. Dental enamel dysplasia of the deciduous teeth.

A memory aid for the tetrad: Movement, Hearing, Gaze, Teeth. This is the author's own mnemonic, not a guideline term.

Bilirubin-induced neurologic dysfunction (BIND) describes subtle developmental disabilities without classical kernicterus findings. On the BIND score, 1-3 is mild, 4-6 moderate and 7-9 severe, and a score of 4 or more predicted poor neurological outcome with 97.4% sensitivity and 87.3% specificity.

Unconjugated bilirubin close to 20 mg/dL has been related to kernicterus. Risk factors include low gestational age, low birth weight, hemolysis, sepsis, cephalohematoma, bruising and exclusive breastfeeding. With timely treatment, the MoHFW guideline notes minimal or no additional neurodevelopmental risk.

Terminology varies by source. A "kernicterus spectrum disorder" label has been proposed. Indian sources use BIND.

Neonatal Jaundice Revision Checklist

Use this order when a question gives you a jaundiced newborn:

1. Check the timing: first 24 hours means pathological until proven otherwise.
2. Check the type: is direct bilirubin above the IAP or MoHFW cut-off?
3. Check the rate of rise and ask for a DAT if it is exceptional.
4. Check for neurotoxicity risk factors, then apply the hour-specific phototherapy line.
5. Check for ABE signs: any advanced sign means exchange irrespective of TSB.
6. If jaundice persists past 2-4 weeks, think thyroid, galactosemia and cholestasis.

Work through related questions in the Pediatrics neonatology practice set. Neonatal jaundice also sits alongside growth problems in infancy, so the failure to thrive workup is a useful next read.

Conclusion

Neonatal jaundice questions reward a fixed sequence: timing, bilirubin type, rate of rise, risk factors, then the treatment line. Learn the structure of the AAP 2022 thresholds rather than isolated numbers, and learn the two Indian direct bilirubin cut-offs by source. Keep biliary atresia and kernicterus in mind as the two diagnoses with the most to lose from delay.